Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Mar 1;48(3):654-8.
doi: 10.1016/j.bone.2010.10.164. Epub 2010 Oct 29.

A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date

Affiliations
Case Reports

A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date

Celia L Gregson et al. Bone. .

Abstract

Fibrodysplasia Ossificans Progressiva (FOP) is a rare, autosomal dominant condition, classically characterised by heterotopic ossification beginning in childhood and congenital great toe malformations; occurring in response to a c.617 G > A ACVR1 mutation in the functionally important glycine/serine-rich domain of exon 6. Here we describe a novel c.587 T > C mutation in the glycine/serine-rich domain of ACVR1, associated with delayed onset of heterotopic ossification and an exceptionally mild clinical course. Absence of great toe malformations, the presence of early ossification of the cervical spine facets joints, plus mild bilateral camptodactyly of the 5th fingers, together with a novel ACVR1 mutation, are consistent with the 'FOP-variant' syndrome. The c.587 T > C mutation replaces a conserved leucine with proline at residue 196. Modelling of the mutant protein reveals a steric clash with the kinase domain that will weaken interactions with FKBP12 and induce exposure of the glycine/serine-rich repeat. The mutant receptor is predicted to be hypersensitive to ligand stimulation rather than being constitutively active, consistent with the mild clinical phenotype. This case extends our understanding of the 'FOP-variant' syndrome.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Location of the novel L196P mutation. (A) Diagram illustrating the ACVR1 domain organisation with the L196P mutation shown in relation to the classical R206H FOP mutation. (B) Packing interactions of L196 in the wild-type ACVR1/FKBP12 structure. (C) The mutant L196 side chain would clash with I266 in the kinase domain (shown by a line of purple spheres). The GS and kinase domains are coloured orange and green, respectively. FKBP12 is coloured blue.
Fig. 2
Fig. 2
Ossification within the soft tissues of the right thigh. The plain radiograph shows great strands and ribbons of ossification within the right thigh consistent with trauma from an intramuscular injection received 11 years earlier.
Fig. 3
Fig. 3
Ossification within the right para-spinal muscles. Plain radiograph of the lumbar spine demonstrates extensive ossification within the right para-spinal muscles.
Fig. 4
Fig. 4
Heterozygosity for the novel mutation c.587 T>C in ACVR1. Direct DNA sequencing electropherogram showing patient heterozygosity for the novel mutation c.587 T>C in exon 6 of the ACVR1 gene and the resultant substitution of leucine at residue 196 in unaffected control with proline in the patient.

Similar articles

Cited by

References

    1. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38:525–7. - PubMed
    1. Connor JM, Evans DA. Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br. 1982;64:76–83. - PubMed
    1. Lin GT, Chang HW, Liu CS, Huang PJ, Wang HC, Cheng YM. De novo 617 G-A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva. J Hum Genet. 2006;51:1083–6. - PubMed
    1. Nakajima M, Haga N, Takikawa K, Manabe N, Nishimura G, Ikegawa S. The ACVR1 617 G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva. J Hum Genet. 2007;52:473–5. - PubMed
    1. Lee DY, Cho TJ, Lee HR, Park MS, Yoo WJ, Chung CY, et al. ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva. J Korean Med Sci. 2009;24:433–7. - PMC - PubMed

Publication types

Substances